Article
Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents
31 Oct 2021
Abstract excerpt
, which encodes the tumor suppressor protein p53, is mutated in about 50% of cancers. In response to cell stressors like DNA damage and after treatment with DNA-damaging therapeutic agents, p53 acts as a transcription factor to activate subsets of target genes which carry out cell fates such as apoptosis, cell cycle arrest, and DNA repair. Target gene selection by p53 is controlled by a complex regulatory network...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
